This activity is part of an ongoing CME/CE initiative to provide information on label changes reported by the FDA. Activities of this nature will be posted on Medscape on a weekly basis. August 19, ...
Impax announced that the Food and Drug Administration (FDA) has approved Glyburide Tablets, the generic version of Sanofi Aventis‘ Diabeta. Diabeta is a second-generation sulfonylurea indicated as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results